Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?

被引：124
|
作者：
Pinheiro, Ruben G. R. [1 ]
Coutinho, Ana Joyce [1 ]
Pinheiro, Marina [1 ]
Neves, Ana Rute [1 ,2 ]
机构：
[1] Univ Porto, LAQV, REQUIMTE, Dept Ciencias Quim,Fac Farm, Rua Jorge Viterbo Ferreira 228, P-4050313 Porto, Portugal
[2] Univ Madeira, CQM Ctr Quim Madeira, Campus Penteada, P-9020105 Funchal, Portugal
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2021年 / 22卷 / 21期
关键词：
Alzheimer's disease; drug delivery; drug targeting; neurodegenerative diseases; Parkinson's disease; SOLID LIPID NANOPARTICLES; PEG-PLA NANOPARTICLES; NICOTINIC ACETYLCHOLINE-RECEPTORS; IIB-IIIA COMPLEX; PLGA NANOPARTICLES; IN-VITRO; LOADED NANOPARTICLES; GLUCOSE TRANSPORTERS; TRANSFERRIN-RECEPTOR; TUMOR VASCULATURE;
D O I：
10.3390/ijms222111654
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The blood-brain barrier (BBB) is a barrier that separates the blood from the brain tissue and possesses unique characteristics that make the delivery of drugs to the brain a great challenge. To achieve this purpose, it is necessary to design strategies to allow BBB passage, in order to reach the brain and target the desired anatomic region. The use of nanomedicine has great potential to overcome this problem, since one can modify nanoparticles with strategic molecules that can interact with the BBB and induce uptake through the brain endothelial cells and consequently reach the brain tissue. This review addresses the potential of nanomedicines to treat neurological diseases by using nanoparticles specially developed to cross the BBB.
引用
收藏
页数：22
相关论文
共 50 条
  • [11] Toxicological status of nanoparticles: What we know and what we don't know
    Missaoui, Wided N.
    Arnold, Robert D.
    Cummings, Brian S.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 295 : 1 - 12
  • [12] Nanoparticles and targeted drug delivery in cancer therapy
    Bahrami, Behdokht
    Hojjat-Farsangi, Mohammad
    Mohammadi, Hamed
    Anvari, Enayat
    Ghalamfarsa, Ghasem
    Yousefi, Mehdi
    Jadidi-Niaragh, Farhad
    IMMUNOLOGY LETTERS, 2017, 190 : 64 - 83
  • [13] Polyp Size Measurement at CT Colonography: What Do We Know and What Do We Need to Know?
    Summers, Ronald M.
    RADIOLOGY, 2010, 255 (03) : 707 - 720
  • [14] How to Develop Drug Delivery System Based on Carbohydrate Nanoparticles Targeted to Brain Tumors
    Silant'ev, Vladimir E.
    Shmelev, Mikhail E.
    Belousov, Andrei S.
    Patlay, Aleksandra A.
    Shatilov, Roman A.
    Farniev, Vladislav M.
    Kumeiko, Vadim V.
    POLYMERS, 2023, 15 (11)
  • [15] Novel advances in targeted drug delivery
    Ozturk-Atar, Kivilcim
    Eroglu, Hakan
    Calis, Sema
    JOURNAL OF DRUG TARGETING, 2018, 26 (08) : 633 - 642
  • [16] Nanoparticles for intracellular-targeted drug delivery
    Paulo, Cristiana S. O.
    das Neves, Ricardo Pires
    Ferreira, Lino S.
    NANOTECHNOLOGY, 2011, 22 (49)
  • [17] Nanoparticles in the ocular drug delivery
    Zhou, Hong-Yan
    Hao, Ji-Long
    Wang, Shuang
    Zheng, Yu
    Zhang, Wen-Song
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2013, 6 (03) : 390 - 396
  • [18] Overcoming the Blood-Brain Barrier: Multifunctional Nanomaterial-Based Strategies for Targeted Drug Delivery in Neurological Disorders
    McLoughlin, Callan D.
    Nevins, Sarah
    Stein, Joshua B.
    Khakbiz, Mehrdad
    Lee, Ki-Bum
    SMALL SCIENCE, 2024, 4 (12):
  • [19] CURRENT APPLICATIONS AND PROSPECTS OF NANOPARTICLES FOR ANTIFUNGAL DRUG DELIVERY
    Nami, Sanam
    Aghebati-Maleki, Ali
    Aghebati-Maleki, Leili
    EXCLI JOURNAL, 2021, 20 : 562 - 584
  • [20] Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier
    Sharma, Garima
    Sharma, Ashish R.
    Lee, Sang-Soo
    Bhattacharya, Manojit
    Nam, Ju-Suk
    Chakraborty, Chiranjib
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 559 : 360 - 372
12345